Acrobiosystems Co., Ltd. Class A

Acrobiosystems Co., Ltd. Class A

SSZSE:301080
74.44
CNY
-1.58
(-2.08%)
1.16EPS
121.19P/E
23.65BMarket Cap
Apr 26Next Earn

Total Valuation

CNY

As of September 30, 2026, Acrobiosystems Co., Ltd. Class A carries a market capitalization of 23.65B, placing it among publicly traded companies globally. Its enterprise value stands at 22.61B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap23.65B
Enterprise Value22.61B

Important Dates

Acrobiosystems Co., Ltd. Class A's next confirmed earnings release is scheduled for April 26, 2027.

Earnings Date4/26/2027

Share Statistics

As of September 30, 2026, Acrobiosystems Co., Ltd. Class A has 167.68M shares outstanding.

Shares Outstanding167.68M

Valuation Ratios

As of September 30, 2026, Acrobiosystems Co., Ltd. Class A trades at a trailing price-to-earnings ratio of 121.19. The price-to-sales ratio is 23.01, and the price-to-book ratio stands at 8.61.

PE Ratio121.19
PS Ratio23.01
PB Ratio8.61
P/TBV Ratio8.72

Enterprise Valuation

As of September 30, 2026, Acrobiosystems Co., Ltd. Class A trades at an EV/EBITDA multiple of 111.93 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 22.04 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 111.93 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 22.61B versus a market cap of 23.65B, with the gap driven by net debt and cash on the balance sheet.

EV / Sales22.04
EV / EBITDA111.93
EV / EBIT111.93

Financial Position

As of September 30, 2026, Acrobiosystems Co., Ltd. Class A maintains a current ratio of 8.96, meaning it holds 9.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 3.95, indicating elevated leverage, while an interest coverage ratio of 891.84 demonstrates strong ability to service its debt obligations.

Current Ratio8.96
Quick Ratio6.26
Debt / Equity3.95
Debt / EBITDA0.54
Interest Coverage891.84

Financial Efficiency

CNY

Over the twelve months ended September 30, 2026, Acrobiosystems Co., Ltd. Class A posted a return on equity (ROE) of 7.26, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 7.02 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 6.45, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 7.04, useful for judging operating efficiency across full business cycles. The company generates approximately 1.11M in revenue per employee across its workforce of 926.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 0.38 indicates how many times Acrobiosystems Co., Ltd. Class A sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Equity (ROE)7.26
Return on Assets (ROA)6.45
Return on Invested Capital (ROIC)7.02
Return on Capital Employed (ROCE)7.04
Revenue Per Employee1.11M
Employee Count926.00
Inventory Turnover0.38

Taxes

CNY

Over the twelve months ended September 30, 2026, Acrobiosystems Co., Ltd. Class A recorded 6.16M in income tax expense. That works out to an effective tax rate of 3.06, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 200.91M, leaving 194.73M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

Income Tax6.16M
Effective Tax Rate3.06

Stock Price Statistics

CNY

As of the close on November 17, 2026, Acrobiosystems Co., Ltd. Class A's stock has gained approximately 23.90% over the past 52 weeks. The 50-day moving average sits at 97.94, while the 200-day moving average is 63.12.

52-Week Price Change23.90%
50-Day Moving Average97.94
200-Day Moving Average63.12

Income Statement

CNY

Over the twelve months ended September 30, 2026, Acrobiosystems Co., Ltd. Class A generated 1.03B in revenue and converted that into 194.73M in net income, yielding earnings per share of 1.16. EBITDA reached 201.97M, while operating income came in at 262.39M.

Revenue1.03B
Gross Profit927.54M
Operating Income262.39M
Pretax Income200.91M
Net Income194.73M
EBITDA201.97M
EBIT201.97M
Earnings Per Share (EPS)1.16

Balance Sheet

CNY

As of September 30, 2026, Acrobiosystems Co., Ltd. Class A holds 1.16B in cash and equivalents against 108.51M in total debt, resulting in a net debt position of -455.91M. Total book value stands at 2.75B, with working capital of 1.47B providing operational flexibility.

Cash & Cash Equivalents1.16B
Total Debt108.51M
Net Debt-455.91M
Equity (Book Value)2.75B
Book Value Per Share16.38
Working Capital1.47B

Cash Flow

CNY

These figures cover the twelve months ended September 30, 2026.

Capital Expenditures-235.82M

Margins

Over the twelve months ended September 30, 2026, Acrobiosystems Co., Ltd. Class A posted a gross margin of 90.42, reflecting its pricing power and cost economics. The operating margin of 25.58 and net profit margin of 18.98 provide insight into operational efficiency.

Gross Margin90.42
Operating Margin25.58
Pretax Margin19.59
Profit Margin18.98
EBITDA Margin19.69

Dividends & Yields

Over the twelve months ended September 30, 2026, Acrobiosystems Co., Ltd. Class A paid dividends of 0.00 per share. The dividend payout ratio of -0.06 is negative because earnings are negative, so the dividend is being paid out of something other than profits, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Total shareholder yield reaches 0.31, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Acrobiosystems Co., Ltd. Class A shareholders.

Payout Ratio-0.06
Shareholder Yield0.31

Stock Splits

Acrobiosystems Co., Ltd. Class A's most recent stock split took place on July 11, 2025 with a 5:7 split ratio.

Last Split Date7/11/2025
Split Ratio5:7

Scores

As of September 30, 2026, Acrobiosystems Co., Ltd. Class A has an Altman Z-Score of 35.89, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score35.89